Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine [Phase 3]

View source ↗

Summary

Phase 3 immunogenicity and safety results for GlaxoSmithKline Poliorix vaccine completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Poliorix (inactivated poliovirus vaccine (IPV))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Poliomyelitis, Poliomyelitis Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2017-04-25